GenomeWeb Feature: For Plant Studies, Genome Size Poses Unique Challenges

Mar 08, 2013

|

NEW YORK (GenomeWeb News) - Some plants, especially angiosperms, have monstrously large genomes, posing a unique set of problems for which researchers conducting plant genomic studies have developed a number of clever solutions.

The average size of an angiosperm genome is about 6.2 gigabases, about twice the size of the human genome, Andrew Leitch, a professor of plant genetics at Queen Mary, University of London, noted, but the range of genome sizes is wide.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Under the Watchful Smart Device Eye

Newsweek discusses the privacy issues raised by digital medicine.

The Poor P Value

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

This Week in Nature

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Push for Predictive Genetic Tests

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

Featured White Papers

The Ultimate Guide to Mouse Clinical Trials

Mar

27

Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.

Apr

30

Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

May

08

Featured Webinar

OncoBEAM ctDNA Testing for Early Response Prediction and Therapy Surveillance in Melanoma and Pancreatic Cancer

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

Menu